A method for screening false positive of cervical abnormal cells based on morphological parameter constraint
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NORTHEAST FORESTRY UNIV
- Filing Date
- 2026-04-02
- Publication Date
- 2026-06-23
AI Technical Summary
Existing deep learning models have a high false positive rate in cervical cell smear detection, making it difficult to effectively distinguish between lesion cells and background noise. Furthermore, their generalization ability is poor when applied across centers, leading to an increased workload for pathologists.
A morphological parameter-constrained cervical abnormal cell screening method is adopted, including overlapping sliding window segmentation, multi-dimensional image quality assessment, soft nonmaximum suppression, morphological mask extraction, and comprehensive discriminant function. Combined with an unsupervised heuristic pseudo-label optimization mechanism, the weights and thresholds are dynamically adjusted.
It significantly reduces the false positive rate, improves the recall rate of real lesion cells, reduces the cost of manual annotation, and realizes efficient and high-precision automated assisted screening of full-view digital slides of cervical liquid-based cytology.
Smart Images

Figure CN122265726A_ABST